Condition
Restenoses, Coronary
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting2
Terminated1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT04573660Recruiting
Abbott Vascular Medical Device Registry
NCT05544864Not ApplicableRecruiting
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
NCT03600948Terminated
BIOFLOW-SV All Comers Registry
NCT03588962Not ApplicableUnknown
Metal Allergy In-Stent Restenosis Study
Showing all 4 trials